US 8377964
Benzimidazole-carboxamide compounds as 5-HT4 receptor agonists
granted A61PA61P1/00A61P1/04
Quick answer
US patent 8377964 (Benzimidazole-carboxamide compounds as 5-HT4 receptor agonists) held by Theravance, Inc. expires Mon Feb 14 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Theravance, Inc.
- Grant date
- Tue Feb 19 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 14 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 17
- CPC classes
- A61P, A61P1/00, A61P1/04, A61P1/10, A61P1/14